T. A. McPherson

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Ian Quirt, W Shelley, Joe Pater et al. · Journal of Clinical Oncology · 1991 · 80 citations

National Cancer Institute, Surgical Oncology, Oncology +15

Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein

John H. Carson, Elisa Barbarese, Pascal Falter‐Braun et al. · Proceedings of the National Academy of Sciences · 1978 · 61 citations · Full text

Myelin Basic Protein, Neurophysiology, Neuroanatomy +15

ADJUVANT BCG IMMUNOTHERAPY FOR MALIGNANT MELANOMA?

Alexander Paterson, D J Willans, John S. Hanson et al. · InPharma · 1983 · 45 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +4

Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.

J.E. Bray, R. U. Lemieux, T. A. McPherson · The Journal of Immunology · 1981 · 43 citations · Full text

Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden.

J.E. Bray, Grant D. MacLean, Frances Dusel et al. · PubMed · 1982 · 38 citations · Full text

Disease Burden, Immunology, Gastroenterology +19